Table 2 Intraoperative and thirty-day postoperative outcomes
Characteristics | GPB group (63) | NGPB group (126) | p |
|---|---|---|---|
Operative time, min, median (range) | 203 (192, 218) | 233 (223, 247) |  < 0.001 |
Blood loss, ml, median (range) | 48 (36, 56) | 67 (58, 76) |  < 0.001 |
Anastomotic height, cm, mean ± SD | 3.17 ± 1.55 | 3.14 ± 1.47 | 0.886 |
Protective ileostomy | 35 (55.6%) | 71 (56.3%) | 0.917 |
Splenic flexure mobilization | 26 (41.3%) | 48 (38.1%) | 0.673 |
Conversion to open surgery | 11 (17.5%) | 26 (20.6%) | 0.604 |
Patients with one cartridge transection | 36/63 (57.1%) | 51/126 (40.5%) | 0.030 |
 Male with one cartridge | 23/37 (62.2%) | 29/79 (36.7%) | 0.010 |
 Female with one cartridge | 13/26 (50.0%) | 22/47 (46.8%) | 0.794 |
 Low rectal cancer with one cartridge | 19/43 (44.2%) | 20/82 (24.4%) | 0.023 |
 Middle rectal cancer with one cartridge | 17/20 (85.0%) | 31/44 (70.5%) | 0.213 |
 BMI > 25 kg/m2 with one cartridge | 14/21 (66.7%) | 19/48 (39.6%) | 0.038 |
 BMI ≤ 25 kg/m2 with one cartridge | 22/42 (52.4%) | 32/78 (41.0%) | 0.233 |
 Tumor > 5 cm with one cartridge | 8/9 (88.9%) | 9/23 (39.1%) | 0.032 |
Patients with more than two cartridges transection | Â | Â | |
|  | 0 | 0 | – |
No. of cartridges,median (range) | 1 (1, 2) | 2 (1, 2) | 0.031 |
Postoperative Complications (< 30 days) | 11 (17.5%) | 23 (18.3%) | 0.893 |
Clavien–Dindo grade |  |  | 0.974 |
 I | 4 (6.3%) | 9 (7.1%) |  |
 II | 3 (4.8%) | 6 (4.8%) |  |
 IIIa | 3 (4.8%) | 4 (3.2%) |  |
 IIIb | 1 (1.6%) | 4 (3.2%) |  |
Types of complications | Â | Â | Â |
 Anatomostic leakage | 2 (3.2%) | 4 (3.2%) | 1.000 |
 Anastomotic bleeding | 1 (1.6%) | 2 (1.6%) | 1.000 |
 Hemorrhage | 1 (1.6%) | 3 (2.4%) | 1.000 |
 Surgery site infections | 4 (6.3%) | 6 (4.8%) | 0.909 |
 Urinary retention | 3 (4.8%) | 7 (5.6%) | 1.000 |
 Thrombosis, thrombus, or embolism | 0 | 1 (0.8%) | 1.000 |